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 27 
Abstract 28 
Rationale  Despite 100 years of psychopharmacological research the extent to which caffeine 29 
consumption benefits human functioning remains unclear. Objectives  To measure the effects 30 
of overnight caffeine abstinence and caffeine administration as a function of level of habitual 31 
caffeine consumption. Methods  Medium-high (n = 212) and non-low caffeine consumers (n 32 
= 157) completed self-report measures and computer-based tasks before (starting at 10.30 33 
AM) and after double-blind treatment with either caffeine (100 mg then 150 mg) or placebo. 34 
The first treatment was given at 11.15 AM and the second at 12.45 PM, with post-treatment 35 
measures repeated twice between 1.45 PM and 3.30 PM. Results  Caffeine withdrawal was 36 
associated with some detrimental effects at 10.30 AM, and more severe effects, including 37 
greater sleepiness, lower mental alertness, and poorer performance on simple reaction time, 38 
choice reaction time and recognition memory tasks, later in the afternoon. Caffeine improved 39 
these measures in medium-high-high consumers, but, apart from decreasing sleepiness, had 40 
little effect on them in non-low consumers. The failure of caffeine to increase mental 41 
alertness and improve mental performance in non-low consumers was related to a substantial 42 
caffeine-induced increase in anxiety/jitteriness that offset the benefit of decreased sleepiness. 43 
Caffeine enhanced physical performance (faster tapping speed and faster simple and choice 44 
reaction times) in both medium-high and non-low consumers. Conclusions  While caffeine 45 
benefits motor performance and tolerance develops to its tendency to increase 46 
anxiety/jitteriness, tolerance to its effects on sleepiness means that frequent consumption fails 47 
to enhance mental alertness and mental performance. 48 
 49 
Key words: Caffeine, Tolerance, Withdrawal, Mental performance, Physical performance, 50 
Reaction time, Cognition, Alertness, Sleep, Anxiety51 
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 52 
Introduction  53 
Judged by the amount and frequency of consumption, caffeine is humankind’s favourite drug. 54 
Caffeine is consumed worldwide predominantly via tea and coffee, its popularity deriving, at 55 
least in part, from the perception that it is a helpful, but mostly harmless, psychostimulant. In 56 
fact, through antagonism of the action of endogenous adenosine at adenosine A1 and A2A 57 
receptors, caffeine has various physiological and behavioural effects (Fredholm et al. 1999). 58 
For example, as well as increasing wakefulness, caffeine raises blood pressure, causes tremor 59 
(reduces hand steadiness), enhances physical performance, and is mildly anxiogenic 60 
(Heatherley et al. 2005; James 2004; Rogers et al. 2010; Warren et al. 2010). However, 61 
determining the benefits or otherwise of caffeine consumption is complicated by the potential 62 
for tolerance to develop to its effects with repeated frequent exposure. It is instructive 63 
therefore to compare the effects of caffeine in individuals who consume caffeine-containing 64 
products frequently with those who do not (or who have abstained from caffeine for a lengthy 65 
period of time – long term withdrawn consumers) (James and Rogers 2005). Rather few 66 
studies have done this. 67 
The first systematic and rigorous human psychopharmacological study of caffeine 68 
was published 100 years ago (Hollingworth 1912). The research was commissioned by the 69 
Coca-Cola Company in defence of a lawsuit accusing it of adding a harmful ingredient, 70 
namely caffeine, to Coca-Cola (Benjamin 2010). Hollingworth’s approach was an intensive 71 
study of a small numbers of individuals, 15 in total, over 45 days. These participants received 72 
caffeine, in doses ranging between 65 and 390 mg, and placebo administered in capsules and 73 
‘syrup’ before and after completing repeated tests assessing ‘mental and motor’ performance. 74 
(Note that currently, regular Coca-Cola currently contains 30 mg of caffeine per 330 ml 75 
serving and, as drunk in the UK, on average tea contains 40 mg, instant coffee 55 mg and 76 
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ground coffee 105 mg of caffeine per typical serving (Heatherley et al. 2006)). 77 
Hollingworth’s results showed that caffeine increased tapping speed (participants were 78 
required to tap a metal rod as quickly as possible on a metal surface) and decreased hand 79 
steadiness (measured by the number of contacts made between a 2.5 mm diameter metal rod, 80 
held in the dominant hand with the arm outstretched, and the side of a 6 mm hole in a brass 81 
plate). At doses of 65 and 130 mg caffeine improved performance on a test of coordination 82 
(requiring insertion of a rod into holes on a board), but at the highest dose (390 mg) 83 
coordination performance was impaired, probably due to the marked increase in tremor at 84 
that dose. Other results, for choice reaction time, number cancellation, calculation and word 85 
retrieval tasks were less clear, but suggested some enhancement of performance. 86 
Hollingworth (1912) commented that “the widespread consumption of caffeinic beverages... 87 
seems to be justified by the results of this experiment” (pages 165-166). However, 50 years 88 
later Weiss and Laties (1962) on reviewing Hollingworth’s study and subsequent research on 89 
caffeine and amphetamines concluded that “the amphetamines seem not only more effective 90 
(in enhancing performance) than caffeine, but less costly in terms of side effects” (page 32). 91 
They were concerned by the evidence that caffeine caused nervousness, irritability and 92 
headache and that it disturbed sleep, though they also concluded that “caffeine does not cause 93 
physical dependence” (page 32).    94 
Today, making a distinction between dependence and addiction, we would argue that, 95 
while caffeine has a low potential for abuse, frequent caffeine consumers are caffeine 96 
dependent, in that withdrawal of caffeine has adverse effects, including lowered alertness, 97 
slowed mental performance and headache (Rogers and Smith 2011). Hollingworth’s research, 98 
while exemplary in many respects, may have confounded effects of caffeine with effects of 99 
caffeine withdrawal. In his main set of experiments participants received caffeine and 100 
placebo on alternate days for 27 days in total, with the doses of caffeine increasing from 65 to 101 
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390 mg (two days at each dose). It is likely that at higher doses the effects of caffeine will 102 
have been assessed against a background of more marked caffeine dependence and acute 103 
withdrawal.  104 
The different effects of caffeine as a consequence of recent exposure to caffeine are 105 
evident from another landmark study. Goldstein et al. (1969) measured alertness, mood and 106 
associated states after caffeine (150 and 300 mg) and placebo in ‘housewives’ who were 107 
reported to be either non-consumers of coffee (n=18) or who drank at least 5 cups of coffee 108 
per day (n=38). (Note that it is implied, though not stated explicitly, by Goldstein et al. that 109 
the non-consumers of coffee, consumed little or no caffeine from other sources, so these 110 
participants can be regarded as non-consumers, or at least very low consumers of caffeine.) 111 
Participants consumed the treatments blind (each on three separate days) after breakfast as 112 
decaffeinated coffee, or decaffeinated coffee with caffeine added, having abstained from all 113 
caffeine-containing drinks after supper the previous day. There were several striking results 114 
for alertness. The first was that the caffeine consumers rated themselves as feeling less alert 115 
before administration of the treatments (caffeine or placebo) than did the non-consumers. 116 
Second, over the next 2 hours caffeine versus placebo increased alertness in consumers; 117 
however, even after the highest dose caffeine, their alertness increased only to the level of 118 
alertness rated by non-consumers when they received placebo. Third, caffeine barely affected 119 
alertness in non-consumers, despite there being considerable room for an increase in scores 120 
(maximum alertness score for the placebo treatment was 1.8 on a 0-3 point scale).  121 
  We have cited these findings as part of the evidence that frequent caffeine 122 
consumption provides no net benefit for alertness and, as a consequence, for performance of 123 
mental tasks requiring sustained attention (James and Rogers 2005). This would indicate 124 
(complete) tolerance to the alerting effects of caffeine in frequent consumers (e.g., 125 
Zwyghuizen-Doorenbos et al. 1990) – with repeated frequent exposure to caffeine, changes to 126 
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adenosine signalling develop to oppose its effects, causing alertness to decline on withdrawal 127 
of caffeine (Fredholm 1999). However, there is a problem with this explanation, as it predicts 128 
increased alertness on initial exposure to caffeine, whereas Goldstein et al. (1969) found no 129 
effect of caffeine on alertness in non-consumers. On the other hand, some authors, including 130 
ourselves, have reported finding that caffeine can increase alertness in non- or low caffeine 131 
consumers (Rogers et al. 2003; Smith et al. 2006), and, more generally, the withdrawal 132 
reversal explanation of effects of caffeine in higher consumers has been widely disputed (e.g., 133 
Smith et al. 2006; Childs and de Wit 2006; Dews et al. 2002; Haskell et al. 2005). 134 
In light of these disagreements, the aim of the present study was to characterise 135 
further the responses to caffeine of non-low and medium-high caffeine consumers. In 136 
particular, we set out to investigate the relationship between the alerting and mental 137 
performance effects of caffeine. For this purpose we assessed specifically mental alertness, 138 
using the cluster of descriptors ‘I feel mentally alert / attentive / able to concentrate / 139 
observant.’ These descriptors are the same as those used by Goldstein et al. (1969), except we 140 
included the descriptor ‘mentally alert’ rather than ‘alert’. Arguably, with or without the word 141 
‘mentally’ this cluster measures mental alertness, rather than a perhaps a more general state 142 
of wakefulness, and from here on in we will use the term mental alertness when referring to 143 
both the present study and Goldstein’s et al. (1969) study. Of course, it is to be expected that 144 
mental alertness would co-vary with sleepiness/wakefulness; however, here, unlike in our 145 
earlier report of some of these data (Rogers et al. 2010), we treated sleepiness/wakefulness 146 
and mental alertness as separate dependent variables. Additionally, based on extensive 147 
evidence of mild anxiogenic effects of caffeine (Rogers et al. 2010), we included measures of 148 
anxiety/jitteriness. Notably, Goldstein et al. (1969) found that caffeine increased jitteriness 149 
(their label for the cluster comprising the descriptors jittery, nervous and shaky) in non-150 
consumers but not in medium-high consumers. We also measured the motor effects of 151 
7 
 
caffeine using a tapping task, because our tests of mental performance, similar to those 152 
employed in many relevant previous studies, required a motor response (i.e., key presses).  153 
Based on withdrawal reversal (James and Rogers, 2005), the main hypotheses for the 154 
present study were that: (1) mental alertness of medium-high caffeine consumers would be 155 
lowered after acute caffeine withdrawal (2), administration of caffeine would subsequently 156 
restore mental alertness to ‘normal’ for the time of day (using non-low consumers’ placebo 157 
level as a benchmark), and (3) these effects of caffeine and caffeine withdrawal on mental 158 
alertness would be mirrored by and related to their effects on sleepiness and performance of 159 
tasks requiring sustained attention. Additionally, based on results from Hollingworth (1912) 160 
and from subsequent studies (e.g., Warren 2010), we predicted that caffeine would enhance 161 
motor performance. We also examined the interrelationships between the effects of caffeine, 162 
sleepiness, anxiety, mental alertness and performance.  163 
 164 
Method 165 
Participants 166 
The results reported here are from a total of 369 participants for whom there was 167 
evidence (salivary caffeine concentration) confirming their caffeine consumer status and 168 
compliance with the requirement to abstain from caffeine overnight before testing (see 169 
Rogers et al. 2010, for details), and complete data available for mental alertness, sleepiness, 170 
anxiety/jitteriness and task performance. These participants were aged between 18 and 62 171 
years, and were non- or light smokers (≤5 cigarettes or equivalent a day – smoking was not 172 
permitted during the test day until after participants left the laboratory). The study protocol 173 
was reviewed and approved by the University of Bristol’s, Department of Experimental 174 
Psychology Human Research Ethics Committee. Participants gave their informed, signed 175 
consent prior to participating in the study. 176 
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 177 
Design and treatments 178 
Based on information recorded in a caffeine intake questionnaire (Rogers et al. 2010) the 179 
participants were divided into ‘non-low’ and ‘medium-high’ caffeine consumers (caffeine 180 
intake of <40 mg/d and ≥40 mg/d, respectively) and randomly assigned to receive caffeine 181 
(caffeine BP anhydrous powder)  at 11.15 AM (100 mg) and 12.45 PM (150 mg) or placebo 182 
(cornflour) on both occasions. Each of these treatments was administered double blind in a 183 
single, white, size 1 cellulose capsule. They were identical in appearance, and were 184 
swallowed with 50 ml of room temperature water. The two doses of caffeine ensured that 185 
systemic caffeine concentration during the afternoon modeled that expected for individuals 186 
consuming two to three cups of ground coffee previously that day.  187 
 (Note that the caffeine questionnaire measured the frequency of participants’ 188 
consumption of caffeine-containing products during the week preceding testing. Caffeine 189 
intake was calculated from consumption frequency using information from various sources 190 
on the caffeine content of these products (teas, coffees, colas, etc.). The 40 mg/d criterion is 191 
supported by the results of our previous analyses comparing effects across four levels of 192 
caffeine consumption in this cohort of participants (Rogers et al. 2010, Figure 1)).  193 
 194 
Measures 195 
The test battery, which included the mental performance and motor tasks and mental alertness 196 
etc. rating scales, was programmed using E-Prime 1.0 (Psychology Software Tools, Science 197 
Plus Group bv, 9747 AA Groningen, The Netherlands) and run on networked PCs with 15-in 198 
colour monitors and standard QWERTY keyboards. These tasks and rating scales were 199 
presented in the following order: tapping, mental alertness etc, recognition memory, simple 200 
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reaction time and choice reaction time, and the full battery took approximately 30 minutes to 201 
complete.   202 
For the tapping task, using their dominant hand, participants were required to tap the 203 
spacebar on the computer keyboard as many times as possible within 30 seconds.  204 
Mental alertness, sleepiness and anxiety/jitteriness were measured using the following 205 
items from the Mood, Alertness and Physical Sensations Scales (MAPSS) (Rogers et al. 206 
2010):  I feel mentally alert / attentive / able to concentrate / observant; I feel sleepy / drowsy 207 
/ half awake; I feel anxious / tense / nervous /on edge combined with I feel jittery / shaky.  208 
These are similar to three of Goldstein’s et al. (1969) eleven items (clusters) (i.e., A = alert, 209 
attentive, observant, able to concentrate; E = sleepy, tired, drowsy, half-awake; C = jittery, 210 
nervous, shaky). Our participants indicated their current state using the horizontal number 211 
pad on the computer keyboard, where 1 represented ‘not at all’ and 9 represented ‘extremely’ 212 
(adjusted to a 0 to 8 scale for the presentation of the results here).   213 
The recognition memory task was similar to the ‘digit vigilance’ task used by Haskell 214 
et al. (2005). Five to-be-remembered digits (0-9) were presented sequentially for 500 ms at 215 
100 ms intervals. These were followed by 30 probe digits also presented sequentially. For 216 
each of these 30 digits participants were required to indicate whether or not it had occurred in 217 
the preceding series of five digits. They did this by pressing keys labeled Y or N on the 218 
computer keyboard (Y = J key and N = F key on the keyboard). This was repeated a total of 219 
six times with different probe and to-be-remembered digits. The dependent variable was the 220 
total number of errors made (i.e., false positives plus false negatives).  221 
For the (variable fore-period) simple reaction time task participants were instructed to 222 
press the space bar as quickly as possible upon the detection of a stimulus, a small star, in the 223 
centre of the computer screen. There was a variable stimulus onset of 1, 2, 3, 4, 7, 9, 12 and 224 
15 s randomised within cycles of eight trials (presentations). The task comprised eight cycles 225 
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(64 trials) in total, which for analysis were divided into four blocks each comprising two 226 
successive cycles. The dependent variable was mean reaction time per block.  227 
For the (two-) choice reaction time task each trial began with the presentation of three 228 
warning crosses in the centre of the computer screen, which were replaced after 500 ms by a 229 
target letter A or B.  This target was presented alone or accompanied by distracter stimuli on 230 
either side. The distracters were stars, or letters (A or B) the same as or different from the 231 
target letter, that were positioned either near or far from the target. Participants were required 232 
to indicate as quickly and accurately as possible whether the target was A or B by pressing 233 
keys labelled A and B on the computer keyboard (A = J key and B = F key). A total of 384 234 
trials were completed. Data from this task can be used to derive a measure of focus of 235 
attention as we did in a previous study of the effects of caffeine and caffeine withdrawal 236 
(Rogers et al., 2005). For the present report, the dependent variables of interest were mean 237 
reaction time and number of errors.  238 
 239 
Procedure 240 
 Between two and six participants were tested on any single day. They arrived at the 241 
laboratory at 9.30 AM having been instructed to abstain from caffeine consumption from at 242 
least 7 PM the previous evening, and they left at 4.15 PM. An initial briefing session was 243 
held in a communal room, and this same room was used for rest periods, lunch (a light lunch 244 
was served at 12.50 AM) and debriefing. The participants completed the mental performance 245 
and tapping tasks and the mental alertness, etc. ratings in a room close by, where each 246 
individual was accommodated in separate, private booth. They completed this battery of tasks 247 
a total of four times: before treatment (baseline, starting at 10.30 AM), starting 45 minutes 248 
after the first dose of caffeine or placebo, and starting 60 and 135 minutes after the second 249 
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dose of caffeine or placebo. This was part of a larger protocol described in fuller detail 250 
elsewhere (Rogers et al., 2010). 251 
 252 
Data analysis 253 
Data were analysed using analysis of variance (ANOVA). Data from measures taken 254 
before administration of caffeine or placebo (pre-treatment baseline) were analysed for 255 
effects of consumer status (non-low versus medium-high consumers). Post-treatment data 256 
were analysed for the effects of caffeine (caffeine versus placebo) and consumer status. In 257 
order to simplify the presentation, only the results from measures taken after the 258 
administration of the second dose of caffeine (means of the data from second and third task 259 
battery) are reported in detail here. Block (four levels) was additionally included as a 260 
repeated measures factor (Greenhouse-Geisser correction applied) in the analysis of the data 261 
from the simple reaction time task. For the post-treatment data multiple paired comparisons 262 
were made using Tukey’s Honestly Significant Difference test (Ferguson & Takane, 1989). 263 
In further analyses of the effects of caffeine, pre-treatment baseline scores were included as a 264 
covariate. Because their scores for a majority of variables differed or tended to differ at 265 
baseline, these particular analyses were carried out separately for non-low and medium-high 266 
consumers (the purpose was to control for baseline differences within consumer status groups 267 
not between these groups). Gender was included as a fixed factor, and age and smoking status 268 
(smoking tended to be associated with caffeine intake – see below) were included as 269 
covariates in all of the above analyses. Standard multiple linear regression (Tabachnick and 270 
Fidell, 2007) was used to examine the contributions of the effects of caffeine on mental 271 
alertness and tapping speed to its effect on simple reaction time. (Out of the four tasks, the 272 
simple reaction time task had most equally both motor and vigilance components.)  We also 273 
examined the contributions of caffeine’s effects on sleepiness and anxiety/jitteriness to its 274 
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effect on mental alertness. These analyses were done for only those participants who received 275 
caffeine and separately for non-low and medium-high caffeine consumers. Alpha was set at 276 
0.05 (2-tail). 277 
 278 
Results 279 
There were 157 non-low and 212 medium-high caffeine consumers (mean ± SD 280 
caffeine consumption = 10.2 ± 11.6 and 235 ± 146 mg/d, and mean ± SD age = 31.7 ± 12.1 281 
and 33.8 ± 12.7 years, respectively), of whom 85 and 109 were female, and 21 and 41 were 282 
smokers. Mean ± SD pre-treatment (baseline, sample taken at 11.10 AM) salivary caffeine 283 
concentration for non-low caffeine consumers were 0.019 ± 0.036 µg/ml (maximum value = 284 
0.17 µg/ml; participants in this group with values >0.2 µg/ml were excluded, Rogers et al. 285 
2010), and for medium-high consumers these values were 0.29 ± 0.38 µg/ml (max. = 1.97 286 
µg/ml; participants in this group with values >2.0 µg/ml were excluded, Rogers et al. 2010). 287 
Corresponding values for salivary concentration of the caffeine metabolite paraxanthine were 288 
0.021 ± 0.036 µg/ml (maximum = 0.18 µg/ml) and 0.29 ± 0.30 µg/ml (maximum = 2.62 289 
µg/ml).  290 
 At 10.30 AM after overnight caffeine abstinence (pre-treatment baseline) the 291 
medium-high caffeine consumers performed worse on the choice reaction time (errors) and 292 
simple reaction time tasks than did the  non-low consumers, and they were also somewhat 293 
less mentally alert and more sleepy (Table 1). 294 
The results for the effects of caffeine and consumer status on mental alertness, 295 
sleepiness, anxiety/jitteriness, mental performance and tapping performance are summarised 296 
in Table 1 and Fig. 1. There was a significant main effect of caffeine for all measures except 297 
recognition memory (p = .065), a significant consumer status effect for all but 298 
anxiety/jitteriness, choice reaction time and tapping performance, and a significant or 299 
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marginally insignificant caffeine by consumer status effect for all but sleepiness and tapping 300 
performance. Generally, the difference between caffeine and placebo treatments was larger 301 
for medium-high consumers, with the striking result being lower mental alertness, greater 302 
sleepiness and, with the exception of the tapping task, poorer performance on all tasks in 303 
medium-high consumers who received placebo than in the other three groups (Fig. 1). Except 304 
for anxiety/jitteriness, caffeine affected medium-high consumers’ responses on all measures: 305 
sleepiness, mental alertness, simple reaction time, choice reaction time, choice reaction time 306 
errors, recognition memory, and tapping speed († in Fig. 1). Caffeine did not affect mental 307 
alertness, or the number of errors made on the recognition memory and choice reaction time 308 
tasks in non-low consumers, though it did reduce their sleepiness, increase their 309 
anxiety/jitteriness and speed their tapping performance, and to a smaller extent it also 310 
speeded their choice reaction time and simple reaction time performance († in Fig. 1).  311 
Block was included in the analysis of simple reaction time performance. The caffeine 312 
by consumer status by block interaction was significant, F(2.44, 874.8) = 3.51, p = 0.02. Fig. 313 
2 shows that, as well being much slower overall on this task, medium-high consumers who 314 
received placebo displayed a marked deterioration in performance across block. The medium-315 
high consumers who received caffeine and the non-low consumers displayed no such 316 
deterioration.  317 
Results of the multiple linear regression analyses are shown in Table 2. For medium-318 
high caffeine consumers the effects of caffeine on mental alertness and on tapping speed 319 
independently predicted its effect on simple reaction time performance. In turn, caffeine’s 320 
effect on mental alertness was predicted by its effect on sleepiness. For non-low consumers, 321 
in contrast, only the effect of caffeine on tapping speed predicted its effect on simple reaction 322 
time performance, and caffeine’s effects on both sleepiness and anxiety/jitteriness contributed 323 
to its effect on mental alertness. Note that the latter (anxiety/jitteriness and mental alertness) 324 
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were inversely related. Further analyses showed that for both non-low and medium-high 325 
consumers the effects of caffeine on sleepiness and anxiety/ jitteriness were unrelated (non-326 
low consumers, r = .07, p > .1; medium-high consumers, r = .04, p > .1), as were the effects 327 
of caffeine on mental alertness and tapping performance (non-low consumers, r = –.06, p > 328 
.1; medium-high consumers, r = –.15, p > .1). Lastly, before caffeine administration 329 
(baseline), mental alertness and tapping speed predicted simple reaction time performance; 330 
and sleepiness, but not anxiety/jitteriness, predicted mental alertness. Here, the pattern of 331 
results did not differ for non-low and medium-high caffeine consumers (data not shown). 332 
 333 
Discussion 334 
The present study helps to resolve some important questions that remain after a century of 335 
research on the effects of caffeine on human behaviour. In particular, in line with the study 336 
hypotheses, they strongly support the claim that medium-high caffeine consumers gain no 337 
acute net benefit for mental alertness and mental performance from their habit (James and 338 
Rogers 2005). That is, the increase in mental alertness experienced by medium-high caffeine 339 
consumers after taking caffeine, and the associated improvement in mental performance, 340 
represent a return to the normal state of affairs (i.e., reversal of adverse effects of caffeine 341 
withdrawal), rather than enhancement to above the normal state. The present results also shed 342 
light on the, perhaps surprising, failure of caffeine to reliably increase mental alertness in 343 
individuals consuming little or no caffeine in their diet (first reported by Goldstein et al. in 344 
1969) – although caffeine reduced sleepiness in non-low consumers this appears to have been 345 
offset by an increase in anxiety/jitteriness, resulting in no net benefit for mental alertness (see 346 
below). In contrast to mental alertness, the results for the tapping task demonstrate that 347 
administration of caffeine increases motor speed irrespective of frequency of habitual 348 
caffeine consumption. As discussed below, these different effects of caffeine on mental 349 
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alertness and motor speed would, in turn, appear to explain rather well the observed pattern 350 
of effects for simple reaction time, choice reaction time and memory performance. 351 
 352 
Effects of acute caffeine abstinence 353 
At 10.30 AM after overnight caffeine abstinence medium-high caffeine consumers 354 
performed more poorly on the simple reaction time and choice reaction time (error measure) 355 
tasks than did the non-low consumers. Correspondingly, their mental alertness was somewhat 356 
lower and their sleepiness somewhat higher than for the non-low consumers. Similar results 357 
for mental alertness and sleepiness have been reported previously (Goldstein 1969; Rogers et 358 
al. 2003). These caffeine consumer status differences at ‘baseline’ were, however, small in 359 
magnitude, and other studies have not found such differences in alertness (Haskell et al. 360 
2005; Smith et al. 2006) or performance (Rogers et al. 2003; Haskell et al. 2005; Smith et al. 361 
2006). Probably, this is due, at least in part, to lack of statistical power. Individual 362 
differences, particularly in performance, are likely to be large in comparison with the effects 363 
of a fairly short period of caffeine withdrawal (similar to or at most 2-3 hours longer than the 364 
period of overnight caffeine abstinence typical for medium-high caffeine consumers). The 365 
present study had a relatively large sample size, and controlling for gender and age in the 366 
analyses reduced the amount of variance in performance unaccounted for. It is also the case 367 
that misclassification of ‘medium-high consumers’ as ‘non-low consumers’ (and vice versa), 368 
and  failure of medium-high consumers to abstain from caffeine overnight as instructed, will 369 
cause group differences in performance and alertness to be underestimated (see introduction). 370 
Measurement of pre-treatment salivary caffeine concentration helped avoid these problems 371 
here. Nonetheless, 42% of our non-low consumer group had detectable levels of caffeine 372 
and/or paraxanthine in their saliva. (Paraxanthine is the major metabolite of caffeine in 373 
humans and is also psychoactive (Okuro et al. 2010).) Perhaps at least some of these 374 
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individuals were in fact consuming sufficient caffeine in their diet to cause them to 375 
experience significant adverse effects when caffeine was withdrawn. This, however, is even 376 
more likely to apply to studies by Haskell et al. (2005) and Smith et al. (2006) which found 377 
no consumer group differences in morning alertness and mental performance. In these studies 378 
baseline salivary caffeine concentrations for ‘non-consumers’ were 0.36 µg/ml (mean value) 379 
(Haskell et al. 2005) and ≤ 2 µg/ml (maximum cut off value, no mean value given) (Smith et 380 
al. 2006). The corresponding values for our non-low consumers were much lower (mean = 381 
0.019, maximum = 0.17 µg/ml).  382 
A possible source of bias which might, on the other hand, work to exaggerate 383 
consumer group differences, concerns the blinding of caffeine abstinence. It may be that 384 
knowledge of caffeine abstinence in the caffeine consumers (‘I haven’t had my morning 385 
coffee/caffeine yet’) would contribute to lower self-reported alertness and greater sleepiness. 386 
Arguably, though, performance is less likely to be affected by this expectancy (cf Haskell et 387 
al. 2005) – indeed, such knowledge might even encourage a compensatory increase in effort, 388 
which would tend to offset decrements in performance.  389 
Overall then, the present results demonstrate adverse effects of overnight caffeine 390 
withdrawal (left hand section of Table 1), which increase in severity as withdrawal continues 391 
into the afternoon (compare the results in Fig. 1 for the non-low and medium-high caffeine 392 
consumers who received placebo).  393 
 394 
Explaining the effects of caffeine and caffeine withdrawal on mental alertness 395 
An important finding of this study is the dissociation of effects of caffeine on mental 396 
alertness (I feel mentally alert / attentive / able to concentrate / observant) and 397 
sleepiness/wakefulness (I feel sleepy / drowsy / half awake) (Fig. 1a and 1c). Mental alertness 398 
was lowest and sleepiness highest in medium-high consumers who received placebo, and the 399 
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effect of caffeine was to normalise their mental alertness and sleepiness – medium-high 400 
consumers treated with caffeine displayed almost the same levels of mental alertness and 401 
sleepiness as non-low consumers treated with placebo. This is fully consistent with 402 
withdrawal reversal, and indicates nearly complete tolerance to these effects of caffeine. 403 
Caffeine also reduced sleepiness in non-low consumers, despite their placebo level of 404 
sleepiness being lower than that of the medium-high consumers. This reduction in sleepiness 405 
was not, however, accompanied by an increase in mental alertness. Why should this be? We 406 
suggest that, while reduced sleepiness (increased wakefulness) might have been expected to 407 
benefit non-low consumers’ mental alertness, this was offset by the increase in anxiety and 408 
jitteriness that they experienced when given caffeine (Fig. 1b). This possibility is supported 409 
by the regression analyses which showed for non-low consumers a negative relationship 410 
between change in anxiety/jitteriness and change in mental alertness after caffeine, which 411 
was independent of the relationship between changes in sleepiness and mental alertness. That 412 
anxiety and jitteriness will have a negative effect on ability to concentrate and sustain 413 
attention, which are components of the mental alertness scale used here, is supported 414 
theoretically and empirically. Eysenck et al. (2007), for example, argue that anxiety impairs 415 
processing efficiency by decreasing attentional control and increasing attention to threat-416 
related stimuli. In the present study, caffeine did not increase in anxiety/jitteriness in 417 
medium-high consumers, presumably because they were tolerant to this effect (Rogers et al. 418 
2010), and for them the decrease in sleepiness after caffeine was accompanied by a related 419 
increase in mental alertness.  420 
A summary of the preceding analysis is presented in Fig. 3. Note that the outcomes of 421 
tolerance to the effects of caffeine on sleepiness and anxiety/jitteriness in medium-high 422 
consumers differ, in that caffeine withdrawal increases sleepiness, but it does not reduce 423 
anxiety/jitteriness (probably mainly because there is little room for the already low level of 424 
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anxiety/jitteriness to decline further). For non-low consumers Fig. 1 indicates that the 425 
magnitude of effects on caffeine on sleepiness and anxiety/jitteriness balance such that there 426 
is no net effect on mental alertness. This balance, however, might vary according to the 427 
population studied (individual susceptibility to the anxiogenic effects of caffeine differs 428 
considerably (Rogers et al. 2010; Yang et al. 2010)), time of day (sleepiness is generally 429 
greater mid-afternoon than mid-morning) and dose of caffeine administered. In relation dose, 430 
in the present study, participants consumed 100 mg of caffeine followed 90 minutes later by 431 
150 mg. The results reported are for the measures taken during the afternoon after the second 432 
dose, although broadly similar effects were apparent for 100 mg. In non-low consumers this 433 
dose increased anxiety/jitteriness and decreased sleepiness, although these effects were 434 
somewhat smaller than after 100 mg + 150 mg caffeine, and there was a small, non-435 
significant, accompanying increase in mental alertness (data not shown). In contrast, in an as 436 
yet unpublished study (Smith, 2011), we observed a significant reduction in mental alertness 437 
in the late afternoon in non-low caffeine consumers given 250 mg of caffeine in a single, 438 
acute dose. It may that at doses of caffeine more representative of individuals’ initial 439 
exposure to caffeine (Rogers et al. 1995), for example 30-50 mg in tea and cola or in small 440 
cups of coffee, that the balance of effects favours increased mental alertness, and that this in 441 
turn helps to encourage further consumption. Supporting a balance in favour of a net benefit 442 
after lower doses of caffeine, Haskell et al. (2005) found that 75 mg, but not 150 mg, of 443 
caffeine significantly decreased ratings of mental fatigue (arguably, the opposite of mental 444 
alertness) in non-low caffeine consumers.  445 
In addition to caffeine dose, and possibly time of day and individual differences, 446 
another factor contributing to apparent discrepancies in results concerning alerting effects of 447 
caffeine is the measurement of alertness. Actually, some findings that show increases in 448 
alertness in non-low caffeine consumers probably correspond to an effect on 449 
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sleepiness/wakefulness rather than specifically mental alertness. For example, the alerting 450 
effect we reported previously in non-low consumers was for data which combined ratings of 451 
alertness and tiredness (Rogers et al. 2003), and the similar effect observed by Smith et al. 452 
(2006) was for alertness measured on a drowsy–alert bipolar scale.  453 
 454 
Faster but not smarter – explaining the effects of caffeine and caffeine withdrawal on 455 
performance  456 
The pattern of results for the recognition memory task and the number of errors 457 
recorded for the choice reaction time task were strikingly similar to that observed for mental 458 
alertness. That is, caffeine did not affect these measures of performance in non-low 459 
consumers, and it did not improve performance in medium-high consumers above the level of 460 
performance displayed by non-low consumers receiving placebo – rather, it appears that the 461 
medium-high consumers receiving placebo were adversely affected by continuing caffeine 462 
withdrawal. Therefore, at least from these results, it would seem that caffeine fails to acutely 463 
enhance mental performance. 464 
By contrast, caffeine affected tapping performance to the same extent in non-low and 465 
medium-high consumers and there was no adverse effect of caffeine withdrawal on this 466 
measure (i.e., speed of tapping did not differ between medium-high and non-low consumers 467 
given placebo). As the tapping task is primarily a test of motor speed and endurance (see 468 
below), with minimal cognitive load, we suggest that the net enhancement of tapping 469 
performance represents a motor effect of caffeine.   470 
A third pattern of results was evident for simple and choice reaction times: there was 471 
a small, but statistically significant, speeding of reaction time in non-low consumers given 472 
caffeine versus their counterparts given placebo, but a larger effect in medium-high 473 
consumers who displayed markedly longer reaction times, especially for simple reaction 474 
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time, if given placebo. We propose that this pattern can be explained by a net speeding of 475 
performance in both non-low and medium-high consumers due to caffeine’s motor effect 476 
(like the tapping task, the reaction time tasks required a motor response), combined with a 477 
withdrawal-related decline in the ability to sustain attention in medium-high consumers. The 478 
latter is, of course, evidenced by these participants’ low ratings of mental alertness which, as 479 
discussed earlier, we suggest is due ultimately to the increase in sleepiness caused by caffeine 480 
withdrawal. 481 
This explanation of the effects of caffeine and caffeine withdrawal on reaction times 482 
is supported by three further sets of results. First, in medium-high caffeine consumers the 483 
effect of caffeine on simple reaction time was predicted by its effects on both tapping 484 
performance and mental alertness, whereas for non-low consumers only caffeine’s effect on 485 
tapping performance predicted its effect on simple reaction time. Second, there was a slowing 486 
in simple reaction across block in the medium-high caffeine consumers given placebo. This 487 
can be interpreted as a vigilance decrement with time on task due to the caffeine-withdrawal-488 
related decrease in mental alertness. No such slowing with time on task in was observed in 489 
the absence of withdrawal (non-low consumers, and medium-high consumers given caffeine). 490 
Third, the speeding of simple reaction time performance in non-low consumers was constant 491 
across block, indicating that, in contrast to the effect of withdrawal, the motor effect of 492 
caffeine did not vary with time on task. Following on from this it is possible to estimate for 493 
the simple reaction time task that caffeine withdrawal slowed reaction time by 52 ms. Our 494 
calculation, the difference between mean placebo and caffeine reaction times in medium-high 495 
consumers minus the difference between mean placebo and caffeine reaction times in non-496 
low consumers (i.e., ((485 – 417) – (437 – 420)), assumes that the purely motor effect of 497 
caffeine in these two groups is the same, namely a speeding of 17 ms (represented by the 498 
placebo-caffeine difference in non-low consumers) (Fig. 1d). This assumption is supported 499 
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by the very similar effect of caffeine on mean tapping speed in non-low and medium-high 500 
consumers (6.1 and 6.7 taps per 30 s, respectively) (Fig. 1h). Arguably, simple reaction time 501 
displayed by placebo-treated non-low consumers represents ‘baseline’ performance on this 502 
task, as it is unaffected by either caffeine or caffeine withdrawal. Compared with this 503 
‘baseline’ (mean = 437, SD = 58), a slowing of reaction time of 52 ms due to caffeine 504 
withdrawal is a large effect as defined by Cohen (1988).  505 
According to the above analysis of the effects of caffeine and caffeine withdrawal on 506 
performance, the difference between the various measures of performance is that the ability 507 
to sustain attention affects recognition memory performance and choice reaction time errors, 508 
motor speed affects tapping performance, whilst both contribute to determining choice and 509 
simple reaction times. In turn, impairment of both speed of information processing and 510 
decision making may be implicated in the withdrawal-related decline in sustained attention, 511 
as evidenced by, respectively, the slowing of reaction time (i.e., the 52 ms increase in the 512 
vigilance-related component of simple reaction time) and the decline in accuracy of 513 
performance (increase in recognition memory and choice reaction time errors). 514 
The speeding of tapping performance by caffeine has been observed previously (e.g., 515 
Heatherley et al., 2005; Hollingworth 1912; Weiss and Laties 1962; Rogers et al., 2005), and 516 
this is consistent with extensive evidence of enhancement by caffeine of physical 517 
performance, including an effect on muscular endurance (Warren et al., 2010; Graham, 2001; 518 
James et al., 2011; Rogers, 2000). The latter is relevant because, although brief, the tapping 519 
task is experienced as fatiguing and tapping rate declines with time on task (data not shown). 520 
Central mechanisms are implicated in the motor effects of caffeine (Barthel et al., 2001; 521 
Specterman et al., 2005), however also a direct effect on muscle is not ruled out (Warren et 522 
al., 2010; James et al., 2011). Notably, the magnitude of the effects of caffeine on physical 523 
performance appears to be unrelated to caffeine consumer status (Rogers, 2000; Warren et al., 524 
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2010; James et al., 2011), as was the effect of caffeine on tapping performance in the present 525 
study (non-low versus in medium-high consumers) and in an earlier study (acutely versus 526 
long-term withdrawn caffeine consumers) (Rogers et al., 2005 – see below).   527 
Therefore, while caffeine clearly does enhance motor performance (faster), as 528 
evidenced by faster reaction times and tapping rate after caffeine in both medium-high and 529 
non-low caffeine consumers, it does not appear to improve mental performance (it failed to 530 
reduce the number of errors made in either the choice reaction time or recognition memory 531 
tasks below that of placebo-treated non-low consumers). Caffeine fails to make medium-high 532 
caffeine consumers ‘smarter’ because, due to tolerance to the effects of caffeine on 533 
sleepiness/wakefulness, they gain no net increase in mental alertness from their habit. 534 
Caffeine, at least in the amounts given in the present study, also fails to increase mental 535 
alertness and improve mental performance in non-low consumers. This is because, although 536 
caffeine reduces sleepiness in non-low consumers, this potential benefit is offset by an 537 
increase in anxiety/jitteriness (Fig. 3). 538 
 539 
Non-low caffeine consumers as a model for studying the effects of caffeine – possible sources 540 
of bias  541 
A possible problem with our interpretation of the different findings for non-low and 542 
medium-high consumers is that these are self-selected groups; that is, perhaps the findings 543 
can be explained by individual differences. For example, those who are constitutionally prone 544 
to excessive sleepiness in the morning might be more likely to turn to caffeine as a remedy 545 
than less sleepy individuals. Against this interpretation is our finding from another study that 546 
morning sleepiness (drowsiness) was the same in non-low caffeine consumers and long-term 547 
withdrawn medium-high consumers, and raised only after acute caffeine withdrawal 548 
(Richardson et al. 1995 – the caffeine consumers were randomised to either acute or long-549 
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term withdrawal). More recently, Sigmon et al. (2009) found the same effect for long-term 550 
versus acute caffeine withdrawal for afternoon ‘tiredness,’ and moreover that caffeine 551 
reduced tiredness by an equal degree under long-term and acute caffeine withdrawal. The 552 
interpretation of these results is that during extended withdrawal adenosine signalling in 553 
(former) caffeine consumers readjusts to eventually match that of non-low consumers 554 
(Richardson et al. 1995; James and Rogers, 2005; Juliano and Griffiths, 2004; Sigmon et al. 555 
2009).   556 
For tapping performance we previously found that the effect of caffeine was nearly 557 
identical in long-term acutely withdrawn medium-high consumers (again participants were 558 
randomised to long-term and acute withdrawal) (Rogers et al., 2005). However, in contrast to 559 
sleepiness/drowsiness/tiredness, there was no detrimental effect of acute withdrawal on 560 
tapping performance (Rogers et al., 2005). Thus for both sleepiness and tapping, results for 561 
non-low consumers closely parallel those for long-term withdrawn medium-high consumers. 562 
In relation to anxiety, it might be that greater susceptibility to the anxiogenic effect of 563 
caffeine deters caffeine consumption. However, this does not appear to be the case (Rogers et 564 
al. 2010), and in another study we found that a vast majority of non-caffeine consumers 565 
selected taste (‘I don’t like the taste’ and ‘I prefer other drinks’) and concern about health 566 
effects (‘It’s not good for my health’), and not anxiety, jitteriness or tension (‘It makes me 567 
feel anxious,’ etc), as reasons for avoiding tea and coffee (Rogers and Smith 2011).  568 
It appears reasonable, therefore, to conclude that the contrasting effects of caffeine 569 
and of caffeine withdrawal we observed in non-low and medium-high caffeine consumers are 570 
related to these participants’ recent history of caffeine exposure, and not to individual 571 
differences pre-dating this exposure.  572 
 573 
Final comments and conclusions 574 
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An important contribution of the present analysis is the dissociation of 575 
sleepiness/wakefulness and mental alertness. In many previous studies on caffeine, including 576 
some of ours, alertness has been treated as being on a continuum with drowsiness and 577 
sleepiness. However, it seems that subjective alertness, or at least subjective mental alertness, 578 
cannot be reduced simply to the absence sleepiness (cf. Shapiro et al. 2006). 579 
In this context, the extent to which tolerance does or does not develop to three 580 
behaviourally distinct effects of caffeine appears to explain very well the effects of caffeine 581 
and caffeine withdrawal on performance. Specifically, with medium-high consumption there 582 
is complete tolerance to the effects of caffeine on daytime sleepiness/wakefulness and on 583 
anxiety/jitteriness, but no tolerance to its effects on motor speed/endurance. The increase in 584 
sleepiness resulting from withdrawal of caffeine underlies a decrease in mental alertness and 585 
impairment of mental performance, all of which are rapidly reversed by caffeine 586 
consumption, without it increasing anxiety/jitteriness. Actually, at 10.30 AM after overnight 587 
caffeine abstinence, differences in performance between medium-high and non-low 588 
consumers, although significant, were fairly small. Therefore, in everyday life medium-high 589 
caffeine consumers may largely avoid the adverse effects of caffeine withdrawal by 590 
consuming caffeine soon after waking in the morning and intermittently thereafter for the rest 591 
of the day (with lower consumption towards evening helping to reduce disruption of sleep) 592 
(Smit and Rogers 2007). Nonetheless, reversal of withdrawal effects following the first 593 
caffeine-containing drink of the day is sufficient to (negatively) reinforce caffeine 594 
consumption habits (Rogers et al., 1995; Rogers and Smith 2011). In contrast to medium-high 595 
caffeine consumers, (non-tolerant) non-low consumers experience an increase in 596 
anxiety/jitteriness after caffeine which decreases, and in the present study completely offset, 597 
any benefit for mental alertness and mental performance arising from reduced sleepiness. 598 
There may be contexts in which non-low consumers could make good use of the latter effect, 599 
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for example when attempting to remain awake at night during a long-distance drive, or trying 600 
to combat the pressure to sleep arising from sleep restriction (Lieberman et al., 2002), but of 601 
course to avoid tolerance and withdrawal, consumption would have to be occasional. Finally, 602 
non-low and medium-high consumers alike can expect to gain a small advantage for physical 603 
performance from caffeine consumption. 604 
605 
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 705 
Figure captions 706 
 707 
Fig. 1. Results for self-reported sleepiness, anxiety/jitteriness and mental alertness (higher 708 
scores indicate higher mental alertness, sleepiness and anxiety/jitteriness; 0-8 point scale) and 709 
for task performance (except for the tapping task, higher scores indicate poorer performance). 710 
Means which do not share a letter (a, b or c) in common differ significantly, p < 0.05 (HSD 711 
test). † denotes that there was a significant effect of caffeine versus placebo within the non-712 
low and/or medium-high consumer groups, p < 0.05 (ANOVA conducted separately for non-713 
low and medium-high consumers, controlling for pre-treatment baseline score). See text for 714 
further statistical details. Participants were required to abstain from caffeine from 7 PM the 715 
evening before the test day, and they given caffeine (100 mg then 150 mg) or placebo at 716 
11.15 AM and 12.45 PM, respectively. Data are for tests conducted between 1.45 PM and 717 
3.30 PM.  718 
 719 
Fig. 2. Results for simple reaction time task performance by block. There was significant 720 
caffeine by consumer status by block interact (p < 0.02) (see also Table 1). See caption to 721 
Fig. 1 for summary of caffeine abstinence and dosing. 722 
 723 
Fig. 3. How the effects of caffeine on sleepiness and anxiety/jitteriness combine to influence 724 
mental alertness.725 
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Table 1  Results for Analyses of the Effects of Caffeine Consumer Status at Baseline and for the Effects of Caffeine and Caffeine 
Consumer Status After Treatment 
 
Measure 
Pre-treatment baseline (df = 1,363) Main and interaction effects of caffeine and consumer statusb (df = 1,359) 
Non-low vs medium-high 
consumersa 
Caffeine Consumer status 
Caffeine by consumer 
status 
Sleepiness, 
0-8 point scale 
2.01 ± 0.16          2.35 ± 0.13 
F = 2.90, p = .09 
F = 26.50, p < .0001  F = 13.58, p = .0003 F = 1.79, P > .1 
Anxiety/Jitteriness, 
0-8 point scale 
1.12 ± 0.09          1.32 ± 0.08 
F = 2.71, p > .1 
F = 16.78, p < .0001 F < 1 F = 18.66, p <.0001 
Mental alertness, 
0-8 point scale 
5.33 ± 0.13          5.02 ± 0.12 
F = 3.02, p = .08 
F = 10.75, p = .001 F = 8.89, p = .003 F = 13.05, p = .0003 
Simple reaction time, 
ms 
391 ± 4        402 ± 3 
F = 4.65, p = .03 
F = 26.84, p < .0001 F = 7.10, p = .008 F = 10.89, p = .001 
Choice reaction time, 
ms 
498 ± 7          511 ± 6 
F = 1.95, p > .1 
F = 10.92, p = .001 F<1 F = 3.30, p = .07 
Choice reaction time, 
number of errors 
8.18 ± 0.57          9.92 ± 0.48 
F = 5.43, p = .02 
F=8.87, p = .003 F = 7.01, p = .008 F = 2.92, p = .09 
Recognition memory,  
number of errors  
13.1 ± 1.1          15.2 ± 0.9 
F = 2.20, p = .14 
F = 3.41, p = .065 F = 5.18, p = .023 F = 6.23, p = .013 
Tapping,  
number of taps/30 s 
183 ± 2          185 ± 1 
F < 1 
F = 9.89, p = .002 F < 1 F < 1 
 
aMeans and SEs are shown.   
bSee Fig. 1 for means and SEs 
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Table 2  Predictors of the Effects of Caffeine on Simple Reaction Time Performance and Mental 
Alertness in Non-low and Medium-high Caffeine Consumers 
 Non-low consumers (n=77) Medium-high consumers (n=106) 
Simple reaction timea    
 Mental alertnessa –.14 –.26* 
 Tapping speeda –.38** –.27* 
 Mental alertnessa    
 Sleepinessa –.35** –.47*** 
 Anxiety/jitterinessa –.38** –.07 
 
Values in the table are standardized coefficients (β) from standard multiple regression analyses 
(*p<.01, **p<.001, ***p<.0001). 
aData in these analyses were post-caffeine (100 + 150 mg) scores minus baseline scores for 
participants who received caffeine. 
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Fig. 3   
 
 
Sleepiness Anxiety/Jitteriness Mental alertness 
Non-low consumer, 
after caffeine  
         ↓        +         ↑        =         →  
Medium-high consumer, 
caffeine withdrawn  
         ↑        +         →        =         ↓  
Medium-high consumer, 
after caffeine  
         →        +         →        =         →  
↓ decreased, ↑ increased, → normal level 
 
